CureVac N.V.

NASDAQ

CVAC

Stock

Yield per half year: +55.99%
Dividend yield: 0%
Sector: Healthcare

Compare companies

Download the report:

Excel

Word

PDF

	CureVac N.V.	Gilead Sciences	Amgen
Capitalization
Price	5.6	116.2	306.58
Price priv.
Number of shares, million	225.27	1255	541
Capitalization, billion	1.99	94.55	140.05
EBITDA, billion	0.2097	4.43	13.36
EV, billion	0.2954	132.19	189.13
Profit and loss report
Net profit, billion	0.1622	0.48	4.09
Revenue, billion	0.5352	28.75	33.42
EPS	0.72	0.3825	7.56
Balance
Assets, billion	0.8028	59	91.84
Debt, billion	0.039	26.71	60.1
Balance cost, billion	0.6966	19.33	5.88
Cash, billion	0.4817	9.99	11.97
Coefficients
Dividend yield, %	0	3.17	2.94
Dividend	0	3.12	9.26
Dividend yield priv., %	0	0	0
Dividend priv.	0	0	0
Dividends/profit, %	0	816.25	118.14
P/S	1.38	4.02	4.22
P/BV	1.06	6	23.99
P/E	4.55	240.57	34.48
Ev/Ebitda	1.41	29.81	14.16
Debt/Ebitda	0.1858	6.02	4.5
Efficiency
ROE	26.73	2.28	67.55
ROA	20.39	0.7926	4.33
ROIC	-43.24	11.06	17
Ebitda margin	39.18	15.42	39.96
Net margin	30.3	1.67	12.24
Momentum
1 week, price changes	+26.98 %	+7.31 %	+3.62 %
1 month, price changes	+34.62 %	+3.98 %	+2.8 %
3 months, price changes	+87.92 %	+8.86 %	+12.75 %
6 months, price changes	+55.99 %	+8.08 %	-2.9 %
1 year, price changes	+73.91 %	+30.89 %	-2.89 %
3 years, price changes	-42.15 %	+43.03 %	+15.98 %
5 years, price changes	-89.61 %	+77.46 %	+19.95 %
10 years, price changes		+77.16 %	+95.67 %

More data >>

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe